天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shenzhen Fez Chemical Technology Co., Ltd.

Firmenname:Shenzhen Fez Chemical Technology Co., Ltd.
Telefon:0755-89483656
E-Mail:henry.hu@phystandard.com
Nationalit?t:CHINA
URL: www.phystandard.com.cn
Produkte insgesamt:40
1

Produktkatalog

Dapagliflozin iMpurity1807632-95-6C21H25BrO6
2-PYRIMIDINAMINE, 4-(3,4-DIHYDRO-1-METHYL-2(1H)-ISOQUINOLINYL)-N-(4-FLUOROPHENYL)-5,6-DIMETHYL-, MONOHYDROCHLORIDE178307-42-1C22H24ClFN4
Neratinib Impurity1348481-03-7C30H29ClN6O4
Mirabegron iMpurity1581285-26-8C16H21ClN2
Ibrutinib iMpurity936351-48-3C12H13ClN2O
LacosaMide iMpurity1219042-50-8C13H18N2O3
Intedanib Impurity2243396-74-7C31H32N6O6
7-epi-Obeticholic acid 3-obeticholate ester1908444-28-9C52H86O7
Fosfluconazole iMpurity
LenalidoMide iMpurity
Sitagliptin IMpurity1675201-14-5C16H12F6N4O
Iptazosole impurity
Ilaprazole Impurity1018229-53-2C11H9N3O
1-Pyrrolidinecarboxylic acid, 4-oxo-2-(3-thiazolidinylcarbonyl)-, 1,1-diMethylethyl ester, (2R)-1415908-67-6C13H20N2O4S
EnzalutaMide IMpurity1839619-50-9C17H8F6N4S
Ceritinib IMpurity
Ticagrelor iMpurity1882095-51-3C27H45N5O8S
Regorafenib iMpurity1333390-56-9C14H9ClF4N2O2
Bedaquiline IMpurity857086-92-1C32H31BrN2O2
Vonoprazan Fumarate(TAK-438) Impurity2792436-54-3
4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide417722-93-1C17H14ClN3O3
AZD9291 impurity
CarfilzoMib IMpurity1541171-65-6C41H61N5O10S
Isavuconazole Impurity21661-87-0C9H5Br2NO
Tedizolid IMpurity1256966-04-7C37H34F2N14O11P2
ApreMilast IMpurity
Nebivolol Hydrochloride Impurities
Avibactam Impurity1797133-98-2C7H12N3NaO6S
Olaparib iMpurity
Posaconazole iMpurity1229428-89-0C37H42F2N8O4
Lapatinib iMpurity746591-42-4C26H18FN3O3
Riociguat IMpurtiy2920299-23-4
Pazopanib iMpurity
Ivabradine IMpurity1616710-50-9C27H35ClN2O6
Istradefylline iMpurity
Edoxaban iMpurities1255529-34-0C14H27N3O3
Empagliflozin (R)-Isomer864070-43-9C23H27ClO7
XLMHAABXFLIUNQ-UHFFFAOYSA-N368451-15-4C24H26O3
PoMalyst iMpurity
Bosutinib1460227-29-5C18H13Cl2N3O3
1
Copyright 2019 ? ChemicalBook. All rights reserved